Behavior and knowledge survey to assess the effectiveness of educational materials in patients treated with AUBAGIO® (teriflunomide) (cross-sectional survey)

30/05/2020
14/03/2024
EU PAS number:
EUPAS31883
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

TERIFC09617_Wave 1 - protocol patient - Aubagio

English (132.23 KB - PDF) View document
Updated protocol

TERIFC09617_Wave 2 - protocol patient - Aubagio

First published: 22/02/2024
English (314.35 KB - PDF) View document
Study results
Study results

Aubagio Patients Wave 1 and 2 combined report-Final

English (534.79 KB - PDF) View document
Study report
Other information